It is currently Tue Oct 21, 2014 1:14 pm

News News of General Discussion

Site map of General Discussion » Forum : General Discussion

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Boston Dad with MS Needs Visitation Rights Victory!

Boston Dad with MS Needs Visitation Rights Victory!
Needs Lawyer's Fee ASAP!

http://www.gofundme.com/di6w34

My name is Joe. Thank you for reading, and for any assistance you can provide. I also encourage you to share this page with anyone you think might understand.

When my ex-wife and I split up nearly five years ago, our divorce agreement granted my ex-wife physical custody of our daughter, with legal custody shared equally. ...
Read more : Boston Dad with MS Needs Visitation Rights Victory! | Views : 329 | Replies : 0


Sleep disorders in MS patients

Sleep Disorders In Multiple Sclerosis Patients Go Largely Undiagnosed: Study

http://www.medicaldaily.com/sleep-disor ... udy-302740

To find out the prevalence of sleep disorders in MS patients, Brass and his colleagues surveyed members of the Northern California Chapter of the National MS Society, who were recruited in 2011.

Of the 11,000 participants interviewed, 2,375 were selected for the survey. Consistent with the reported epidemiology of multiple sclerosis, the majority (81 percent) were ...
Read more : Sleep disorders in MS patients | Views : 270 | Replies : 0


Oceans of Hope

I don't know if anyone has heard of this organization, but it is worth a search.

It's a group formed in the Netherlands by a Neuropsych. He got some backing from Biogen and bought a 67 foot sailboat. His dream, which has strted is to circumnavigate the earth on the boat manned mostly by folks with MS. He's got 4 regular folks on board as well.
If anyone has dreams to sail, send an application. ...
Read more : Oceans of Hope | Views : 247 | Replies : 0


2014 ACTRIMS/ECTRIMS

For all the breaking #MS news from 2014 ACTRIMS/ECTRIMS please see http://www.ms-uk.org/MSnews
Read more : 2014 ACTRIMS/ECTRIMS | Views : 257 | Replies : 0


Myelin measure in MS tracks patient disability

Whole-brain measures of myelin water fraction (MWF) -- reflecting the amount of myelin present in brain tissue -- correlated significantly with disease duration and disability levels in multiple sclerosis, supporting a role for MWF in patient management and as an outcome in clinical trials, a researcher said here.

In a cross-sectional study of 141 MS patients and 10 neurologically healthy controls, the "skew" of one of two peaks seen in the distribution of MWF across ...
Read more : Myelin measure in MS tracks patient disability | Views : 210 | Replies : 0


Severe optic nerve damage in MS not a hurdle.....

Severe optic nerve damage in MS not a hurdle to some children

There is a clear subset of pediatric patients with demyelinating disease who have substantial damage to the nerve layer in the retina but nevertheless have no vision loss, a new study shows.

"Understanding how this subset of patients recover functionally after optic nerve damage could lead to great insight into best acute treatment options and a better understanding of brain plasticity and neural ...
Read more : Severe optic nerve damage in MS not a hurdle..... | Views : 183 | Replies : 0


Plegridy two year data confirms safety and efficacy in MS

Plegridy two year data confirms safety and efficacy in MS patients

Biogen Idec today announced new data from the second year of its Phase 3 ADVANCE clinical trial that show the positive treatment effects of Plegridy™ (peginterferon beta-1a) were maintained in people with relapsing forms of multiple sclerosis (RMS) beyond the first year of the study. These results were presented at the sixth Triennial Joint Meeting of the Americas Committee for Treatment and Research in ...
Read more : Plegridy two year data confirms safety and efficacy in MS | Views : 266 | Replies : 0


Sanofi aims to grow Genzyme unit with new drugs.....

Sanofi aims to grow Genzyme unit with new drugs and acquisitions

Sanofi rare disease unit Genzyme hopes to become a leader in the multiple sclerosis (MS) field with the help of new products developed in-house but also through acquisitions, senior Genzyme executives told Reuters.

The Cambridge, Massachusetts company is confident in the commercial success of its two MS drugs Lemtrada and Aubagio and is "very active" in its hunt for external growth, Bill Sibold, the ...
Read more : Sanofi aims to grow Genzyme unit with new drugs..... | Views : 191 | Replies : 0


To boost or supress autoimmunity, that is the question

Breaking peripheral immune tolerance to CNS antigens in neurodegenerative diseases: Boosting autoimmunity to fight-off chronic neuroinflammation.

Schwartz M, Baruch K.

Abstract

Immune cell infiltration to the brain's territory was considered for decades to reflect a pathological process in which immune cells attack the central nervous system (CNS); such a process is observed in the inflammatory autoimmune disease, multiple sclerosis (MS).

As neuroinflammatory processes within the CNS parenchyma are also common to other CNS pathologies, regardless ...
Read more : To boost or supress autoimmunity, that is the question | Views : 257 | Replies : 1


People with multiple sclerosis lose myelin in grey matter

People with multiple sclerosis (MS) lose myelin in the grey matter of their brains and the loss is closely correlated with the severity of the disease, according to a new magnetic resonance imaging (MRI) study. Researchers said the findings could have important applications in clinical trials and treatment monitoring. The study appears online in the journal Radiology.

Loss of myelin, the fatty protective sheath around nerve fibres, is a characteristic of MS, an inflammatory disease ...
Read more : People with multiple sclerosis lose myelin in grey matter | Views : 275 | Replies : 2


 

Login  •  Register


Statistics

Total posts 220783 • Total topics 22876 • Total members 14447


Contact us | Terms of Service